Plasma-based antigen persistence in the post-acute phase of COVID-19.
作者信息
Peluso Michael J, Swank Zoe N, Goldberg Sarah A, Lu Scott, Dalhuisen Thomas, Borberg Ella, Senussi Yasmeen, Luna Michael A, Chang Song Celina, Clark Alexus, Zamora Andhy, Lew Megan, Viswanathan Badri, Huang Beatrice, Anglin Khamal, Hoh Rebecca, Hsue Priscila Y, Durstenfeld Matthew S, Spinelli Matthew A, Glidden David V, Henrich Timothy J, Kelly J Daniel, Deeks Steven G, Walt David R, Martin Jeffrey N
机构信息
Division of HIV, Infectious Diseases, and Global Medicine, University of California, University of California San Francisco, San Francisco, CA 94110, USA.
Harvard Medical School, Boston, MA, USA; Department of Pathology, Brigham & Women's Hospital, Boston, MA, USA; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.
出版信息
Lancet Infect Dis. 2024 Jun;24(6):e345-e347. doi: 10.1016/S1473-3099(24)00211-1. Epub 2024 Apr 8.
Abstract
摘要
相似文献
1
Plasma-based antigen persistence in the post-acute phase of COVID-19.
Lancet Infect Dis. 2024 Jun;24(6):e345-e347. doi: 10.1016/S1473-3099(24)00211-1. Epub 2024 Apr 8.
2
Ultra-Sensitive Serial Profiling of SARS-CoV-2 Antigens and Antibodies in Plasma to Understand Disease Progression in COVID-19 Patients with Severe Disease.
Clin Chem. 2020 Dec 1;66(12):1562-1572. doi: 10.1093/clinchem/hvaa213.
3
Duration of post-COVID-19 symptoms is associated with sustained SARS-CoV-2-specific immune responses.
JCI Insight. 2021 Aug 9;6(15):e151544. doi: 10.1172/jci.insight.151544.
4
A novel strategy for identifying biomarker in serum of patient with COVID-19 using immune complex.
Signal Transduct Target Ther. 2022 Feb 28;7(1):63. doi: 10.1038/s41392-022-00909-z.
5
An antigen microarray protocol for COVID-19 serological analysis.
STAR Protoc. 2021 Sep 17;2(3):100815. doi: 10.1016/j.xpro.2021.100815. Epub 2021 Aug 26.
6
Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray.
Nat Commun. 2021 Jan 4;12(1):6. doi: 10.1038/s41467-020-20095-2.
7
A Next-Generation Rapid, Accurate SARS-CoV-2 Antibody Test.
JAMA. 2021 May 11;325(18):1825. doi: 10.1001/jama.2021.6333.
8
Quantification of SARS-CoV-2 antigen levels in the blood of patients with COVID-19.
Sci China Life Sci. 2021 Jul;64(7):1193-1196. doi: 10.1007/s11427-020-1830-8. Epub 2020 Nov 26.
9
SARS-CoV-2 Antigenemia as a Confounding Factor in Immunodiagnostic Assays: A Case Study.
Viruses. 2021 Jun 14;13(6):1143. doi: 10.3390/v13061143.
10
A Serological Snapshot of COVID-19 Initial Stages in Israel by a 6-Plex Antigen Array.
Microbiol Spectr. 2021 Oct 31;9(2):e0087021. doi: 10.1128/Spectrum.00870-21. Epub 2021 Oct 6.
引用本文的文献
1
Immunization as Protection Against Long COVID in the Americas: A Scoping Review.
Vaccines (Basel). 2025 Jul 31;13(8):822. doi: 10.3390/vaccines13080822.
2
T Cell Dynamics in COVID-19, Long COVID and Successful Recovery.
Int J Mol Sci. 2025 Jul 27;26(15):7258. doi: 10.3390/ijms26157258.
3
CROI 2025: Acute and Postacute COVID-19.
Top Antivir Med. 2025 Jun 30;33(3):555-568.
4
Peripheral immune progression to long COVID is associated with mitochondrial gene transcription: A meta-analysis.
Mitochondrion. 2025 Jul 28;85:102072. doi: 10.1016/j.mito.2025.102072.
5
Cytokine profiles associated with persisting symptoms of post-acute sequelae of COVID-19.
Korean J Intern Med. 2025 Jul;40(4):667-675. doi: 10.3904/kjim.2024.217. Epub 2025 Jul 1.
6
Mesenchymal stromal cell secretome reduces lung injury and thrombo-inflammation induced by SARS-CoV-2 spike protein.
Stem Cell Res Ther. 2025 Jul 1;16(1):324. doi: 10.1186/s13287-025-04472-6.
7
Neuroimmune pathophysiology of long COVID.
Psychiatry Clin Neurosci. 2025 Jun 19. doi: 10.1111/pcn.13855.
8
SARS-CoV-2 Spike Protein and Long COVID-Part 1: Impact of Spike Protein in Pathophysiological Mechanisms of Long COVID Syndrome.
Viruses. 2025 Apr 25;17(5):617. doi: 10.3390/v17050617.
9
Prevalence of Long COVID in exposed Groups in Peru and Kenya.
medRxiv. 2025 Apr 29:2025.04.28.25326537. doi: 10.1101/2025.04.28.25326537.
10
Multi-layered deep immune profiling, SARS-CoV-2 RNAemia and inflammation in unvaccinated COVID-19 individuals with persistent symptoms.
Commun Med (Lond). 2025 May 5;5(1):155. doi: 10.1038/s43856-025-00832-8.
本文引用的文献
1
Replication-Competent Virus Detected in Blood of a Fatal COVID-19 Case.
Ann Intern Med. 2024 Jan;177(1):113-115. doi: 10.7326/L23-0253. Epub 2023 Dec 12.
2
SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC).
Nat Immunol. 2023 Oct;24(10):1616-1627. doi: 10.1038/s41590-023-01601-2. Epub 2023 Sep 4.
3
Trends in Laboratory-Confirmed SARS-CoV-2 Reinfections and Associated Hospitalizations and Deaths Among Adults Aged ≥18 Years - 18 U.S. Jurisdictions, September 2021-December 2022.
MMWR Morb Mortal Wkly Rep. 2023 Jun 23;72(25):683-689. doi: 10.15585/mmwr.mm7225a3.
4
Long COVID: major findings, mechanisms and recommendations.
Nat Rev Microbiol. 2023 Mar;21(3):133-146. doi: 10.1038/s41579-022-00846-2. Epub 2023 Jan 13.
5
Persistent Circulating Severe Acute Respiratory Syndrome Coronavirus 2 Spike Is Associated With Post-acute Coronavirus Disease 2019 Sequelae.
Clin Infect Dis. 2023 Feb 8;76(3):e487-e490. doi: 10.1093/cid/ciac722.
6
Persistence, Magnitude, and Patterns of Postacute Symptoms and Quality of Life Following Onset of SARS-CoV-2 Infection: Cohort Description and Approaches for Measurement.
Open Forum Infect Dis. 2021 Dec 21;9(2):ofab640. doi: 10.1093/ofid/ofab640. eCollection 2022 Feb.
7
Single molecule array (Simoa) assay with optimal antibody pairs for cytokine detection in human serum samples.
Analyst. 2015 Sep 21;140(18):6277-82. doi: 10.1039/c5an01238d.
Zotero 插件